PubMed Health⌕ Search

Biomedical subjects

F Sagher

Publications and source records attributed to F Sagher.

At least 19 recordsLinked to original sources
PubMed1999

Iron status of Libyan infants with urinary tract infection.

Serum iron, serum total iron binding capacity and tranferrin saturation levels were measured in 45 infants, of whom 19 had urinary tract infections confirmed by positive suprapubic aspiration. The control group comprised 26 healthy infants with negative results. Mean serum iron and transferrin saturation values were significantly lower in infants with urinary tract infection compared with the control group (P < 0.01 and P < 0.001 respectively), especially if the cultured organism was Escherichia coli (P < 0.01, P < 0.02). Total iron binding capacity was within the normal range. We conclude that iron deficiency is not a major factor in the etiopathogenesis of urinary tract infection in Libyan infants.

Anemia, Iron-Deficiency↗
PubMed1999

Bronchoconstrictor effect of exercise in healthy Libyan children in Tripoli.

To study the effects of short-term exercise on pulse rate and peak expiratory flow rate in healthy Libyan schoolchildren, 650 healthy students (330 boys, 320 girls) aged 4.5 years to 14.9 years were selected from four randomly chosen Tripoli primary schools. Pulse rate and peak expiratory flow rate were measured at rest in standing position and immediately after rhythmic short-term exercise. Exercise markedly increased pulse rate (mean differences being significantly higher in girls than boys) and markedly reduced peak expiratory flow rate (mean difference being significantly higher in boys than girls). We found 10% of the children had a reduction in peak expiratory flow rate > or = 15% from the baseline.

Adolescent↗
PubMed1997

Use of cisapride in treatment of constipation in children.

BACKGROUND: Chronic constipation is a common problem in children. We observed the effects of cisapride in the management of idiopathic constipation in children. METHODS: Thirty-seven children with a history of constipation (i.e., pain and difficulty or delay in defecation for > 3 months) were recruited and randomly assigned to 8 weeks of treatment with either cisapride, 0.2 mg/kg three times daily, or matching placebo after a 2-week run-in period in a double-blind, parallel-group study design. In phase 1 (2 weeks), patients had plain abdominal radiographs to assess degree of faecal load, and those with impaction were given laxatives. After satisfactory clearance of faeces, total gastrointestinal transit time and orocaecal transit time were measured. In phase 2, after 8 weeks of treatment with either cisapride or placebo (0.2 mg/kg t.d.s.), the transit studies were repeated. RESULTS: Compared with placebo, cisapride did not improve either stool frequency or transit time in this study population. CONCLUSION: This study did not demonstrate a clinical role for the use of cisapride in the treatment of idiopathic constipation in children.

Adolescent↗
PubMed1975

[World survey on the use of thalidomide in leprosy reaction].

Review of the answers of a questionary sent to 62 different Leprosy Departments. The results indicate that in 99% of lepromatous patients with lepra-reactions, the response to thalidomide was satisfactory. In the tuberculoid and borderline types of lepra, the results were not good.

Drug Evaluation↗
PubMed1970

Therapy of leprosy.

The latest developments and ideas in the therapy of leprosy are discussed, the need for long-term studies being stressed. The therapeutic efficacy and effective dosages of some sulfones (especially diaphenylsulfone), thiambutosine and long-acting sulfonamides such as sulfamethoxine and sulfalene, are considered. The possibilities for two newer drugs, 4,4'-diacetyldiaminodiphenylsulfone and clofazimine (B-663), both still in the early stages of evaluation, are also described and the potential value of thalidomide in treatment of the lepra reaction is discussed. The authors make a number of recommendations for controlled trials and lines of investigation and, in particular, favour a biochemical approach to the correction of defective host defences. Diaphenylsulfone is still considered the drug of choice for use in the therapy of leprosy.

Aniline Compounds↗